These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17194901)

  • 1. Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer.
    D'Amico AV
    J Clin Oncol; 2007 Jan; 25(1):8-9. PubMed ID: 17194901
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined radiotherapy and hormone therapy in non-metastatic adenocarcinoma of prostate].
    Lopez S; Simon JM; Mazeron JJ
    Bull Cancer; 2009 Mar; 96(3):261-70. PubMed ID: 19318304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant hormonal treatment combined with external irradiation in the management of prostate cancer].
    Bolla M; Artignan X; Fourneret P; Brochon D; Ringeisen F; Descotes JL
    Bull Cancer; 2006 Nov; 93(11):1101-5. PubMed ID: 17145579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer].
    Bolla M; Fourneret P; Descotes JL
    Bull Cancer; 2008 Dec; 95(12):1213-8. PubMed ID: 19091656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deprivation therapy for prostate cancer.
    Bahnson R
    J Urol; 2007 Oct; 178(4 Pt 1):1148. PubMed ID: 17698142
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocrine treatment of prostate cancer: standard treatment and new perspectives.
    Boccardo F; Pace M
    In Vivo; 1993; 7(5):423-4. PubMed ID: 8110985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy.
    Palma D; Pickles T
    Cancer; 2008 May; 112(10):2322-3; author reply 2323. PubMed ID: 18327816
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer: non-metastatic.
    Wilt T
    Clin Evid; 2002 Jun; (7):812-23. PubMed ID: 12230707
    [No Abstract]   [Full Text] [Related]  

  • 9. A call for more with a desire for less: pelvic radiotherapy with androgen deprivation in the treatment of prostate cancer.
    Pollack A
    J Clin Oncol; 2003 May; 21(10):1899-901. PubMed ID: 12743140
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk-based management of prostate cancer.
    D'Amico AV
    N Engl J Med; 2011 Jul; 365(2):169-71. PubMed ID: 21751910
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of hormonal therapy for prostate cancer.
    Carter HB; Isaacs JT
    Prog Clin Biol Res; 1990; 350():129-40. PubMed ID: 2201039
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved prostate cancer treatment.
    Health News; 2002 Sep; 8(9):8. PubMed ID: 12229905
    [No Abstract]   [Full Text] [Related]  

  • 13. The androgen receptor for the radiation oncologist.
    Quero L; Rozet F; Beuzeboc P; Hennequin C
    Cancer Radiother; 2015 May; 19(3):220-7. PubMed ID: 25921704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials.
    Bria E; Cuppone F; Giannarelli D; Milella M; Ruggeri EM; Sperduti I; Pinnarò P; Terzoli E; Cognetti F; Carlini P
    Cancer; 2009 Aug; 115(15):3446-56. PubMed ID: 19484790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New aspects of anti-androgenic therapy of prostatic cancer].
    Portnoĭ AS
    Urol Nefrol (Mosk); 1985; (3):69-73. PubMed ID: 3892832
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer.
    Bolla M; Descotes JL; Artignan X; Fourneret P
    BJU Int; 2007 Jul; 100 Suppl 2():44-7. PubMed ID: 17594359
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormone therapy and radiotherapy for intermediate risk prostate cancer.
    Lee I; Sandler H
    Semin Radiat Oncol; 2008 Jan; 18(1):7-14. PubMed ID: 18082583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefits of early androgen blockade.
    Maroni PD; Crawford ED
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):317-29. PubMed ID: 18471789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High risk prostate cancer results of one year RT-HT].
    Delaporte V; Muracciole X; Lechevalier E; Bastide C; Cowen D; Rossi D; Coulange C
    Prog Urol; 2005 Dec; 15(6 Suppl 1):1256-61. PubMed ID: 16734214
    [No Abstract]   [Full Text] [Related]  

  • 20. Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.
    Yoon FH; Gardner SL; Danjoux C; Morton G; Cheung P; Choo R
    J Urol; 2008 Oct; 180(4):1438-43; discussion 1443-4. PubMed ID: 18710743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.